PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 59 filers reported holding PREVAIL THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $248,000 | +210.0% | 10,768 | +36.6% | 0.00% | – |
| Q3 2020 | $80,000 | -25.2% | 7,882 | +9.6% | 0.00% | – |
| Q2 2020 | $107,000 | +75.4% | 7,194 | +42.7% | 0.00% | – |
| Q1 2020 | $61,000 | +52.5% | 5,043 | +95.8% | 0.00% | – |
| Q4 2019 | $40,000 | +60.0% | 2,575 | +25.1% | 0.00% | – |
| Q3 2019 | $25,000 | – | 2,059 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,392,556 | $29,381,000 | 3.71% |
| Orbimed Advisors | 13,822,463 | $169,740,000 | 3.22% |
| Omega Fund Management, LLC | 668,908 | $8,214,000 | 2.54% |
| RA Capital Management | 3,363,605 | $41,305,000 | 2.46% |
| Boxer Capital, LLC | 1,123,105 | $13,792,000 | 1.00% |
| BVF INC/IL | 656,483 | $8,062,000 | 0.85% |
| DAFNA Capital Management LLC | 75,000 | $921,000 | 0.35% |
| SPHERA FUNDS MANAGEMENT LTD. | 90,217 | $1,108,000 | 0.17% |
| Clal Insurance Enterprises Holdings Ltd | 292,000 | $3,586,000 | 0.09% |
| VHCP Management III, LLC | 4,408 | $54,000 | 0.03% |